Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine in Metastatic Hormone-Resistant Prostate Cancer
NCT00003259Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Oct 1997
- Primary completion
- Sep 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine in prostate cancer (PCa), sponsored by Swiss Group for Clinical Cancer Research. Started Oct 1997; status: completed.
02
Drugs
vinorelbine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003259.